Related Experiment Video
Updated: Sep 26, 2026

Human Blastocyst Biopsy and Vitrification
Published on: July 26, 2019
A placebo-controlled treatment trial of Blastocystis hominis infection with metronidazole
Luciano Nigro1, Licia Larocca, Laura Massarelli
1Infectious Diseases Unit, University of Catania, c/o Ascoli-Tomaselli Hospital, via Passo Gravina 185, 95125 Catania, Italy.
Abstract:
Blastocystis hominis, previously considered a harmless yeast, is now classified as a protozoan inhabiting the human intestinal tract. The pathogenicity of B. hominis remains controversial and is currently the subject of extensive debate.1- 5 As a result of the uncertainty surrounding the pathogenic role of B. hominis, large-scale treatment trials of B. hominis infection have so far been lacking. In spite of this, several drugs have been reported to be active against the parasite.6-8 The present study was carried out in order to evaluate the efficacy of metronidazole treatment in inducing clinical remission and parasitologic eradication in immunocompetent individuals with B. hominis as the only evident cause of diarrhea.
Related Concept Videos
Trichomoniasis
Anthelminthic Agents
Amebiasis
Toxoplasmosis
